Clinical trials

  • Oncolytic adenovirus encoding tumor necrosis factor alpha (TNF-alpha) and interleukin-2 (IL-2) for Solid Tumors
  • Etoricoxib for Postoperative pain after mandibular third molar extraction
  • Olaparib for Metastatic pancreatic ductal adenocarcinoma
  • VERICIGUAT for Treatment-resistant hypertension
  • RO7837195 for Moderately to severely active ulcerative colitis
  • GSK5460025A for Colorectal cancer | Endometrial cancer | dMMR/MSI-H solid tumours
  • SODIUM CHLORIDE for Traumatic brain injury
  • FIBRIN MATRIX for Pterygium
  • LY3537021 for Nausea|Vomiting|Drug-related adverse reactions|Neoplasms
  • vedolizumab
  • Darolutamide for Prostate adenocarcinoma (high-risk localized or locally advanced)
  • Upadacitinib for Acute anterior uveitis|Axial spondyloarthritis